A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer.
M. Aglietta, C. Barone, M. Sawyer, M. Moore +9 more
2014Annals of Oncology138 citations Open access
Semantic Scholar

